⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 19, 2020Cancer

Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy

Michael Xiang Daniel T. Chang Erqi L. Pollom

View at Publisher

Ask AI

Bookmark

Share

Abstract

The risk of a second cancer diagnosis was similar after IMRT versus 3DCRT, whereas PBRT was associated with a lower risk of second cancer risk. Future work is warranted to determine the cost-effectiveness of PBRT and to identify the population best suited for this treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xiang et al. (2020) studied this question.

synapsesocial.com/papers/69d7069ce328128020aa8ae8 https://doi.org/10.1002/cncr.32938

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG‐2015 French Innovative Leukemia Organization phase 2 randomized trialCancer · 2026
2The evolving role of perioperative systemic therapy in bladder cancerCancer · 2026
3A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancerCancer · 2026
4Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds itCancer · 2026
5Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experienceCancer · 2026

Population‐level diagnostic and radiation treatment trends of low‐risk prostate cancerCancer · 2026
Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patientsCancer · 2026
Generative artificial intelligence in medical oncology: A clinically focused narrative review of large language, vision‐language, and agentic artificial intelligence systemsCancer · 2026
Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma ConsortiumCancer · 2026
Cancer risks associated with BRCA1 and BRCA2 : Overview and managementCancer · 2026

More from Cancer

More from Stanford University

More from Palo Alto Veterans Institute for Research